As of 2025-03-15, the Relative Valuation of BetterLife Pharma Inc (BETR.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 CAD, the upside of BetterLife Pharma Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-02-26 | -3.17 |
| 2025-02-25 | -3.48 |
| 2025-02-24 | -3.48 |
| 2025-02-21 | -3.48 |
| 2025-02-20 | -3.48 |
| 2025-02-19 | -3.48 |
| 2025-02-18 | -3.48 |
| 2025-02-14 | -3.64 |
| 2025-02-13 | -4.28 |
| 2025-02-12 | -3.48 |
| 2025-02-11 | -3.48 |
| 2025-02-10 | -3.48 |
| 2025-02-07 | -3.33 |
| 2025-02-06 | -3.48 |
| 2025-02-05 | -3.64 |
| 2025-02-04 | -4.12 |
| 2025-02-03 | -4.12 |
| 2025-01-31 | -4.12 |
| 2025-01-30 | -4.12 |
| 2025-01-29 | -4.12 |
| 2025-01-28 | -3.96 |
| 2025-01-27 | -3.96 |
| 2025-01-24 | -4.43 |
| 2025-01-23 | -4.75 |
| 2025-01-22 | -4.12 |
| 2025-01-21 | -4.12 |
| 2025-01-20 | -4.12 |
| 2025-01-17 | -3.64 |
| 2025-01-15 | -3.17 |
| 2025-01-14 | -3.48 |
| 2025-01-13 | -3.64 |
| 2025-01-10 | -3.64 |
| 2025-01-09 | -3.80 |
| 2025-01-08 | -3.80 |
| 2025-01-07 | -3.64 |
| 2025-01-06 | -3.33 |
| 2025-01-02 | -3.48 |
| 2024-12-31 | -3.17 |
| 2024-12-27 | -3.33 |
| 2024-12-23 | -3.33 |
| 2024-12-20 | -3.33 |
| 2024-12-19 | -3.33 |
| 2024-12-18 | -3.33 |
| 2024-12-17 | -3.33 |
| 2024-12-16 | -3.48 |
| 2024-12-13 | -3.48 |
| 2024-12-12 | -3.64 |
| 2024-12-11 | -3.33 |
| 2024-12-10 | -3.33 |
| 2024-12-09 | -3.64 |